Lilly Alzheimer Failure Threatens Prospects for Similar Pfizer, J&J Drugs

Pfizer Inc. , Johnson & Johnson , and a half dozen competitors are committed to a research strategy for Alzheimer’s disease that has resulted in a string of study failures, the most recent involving Eli Lilly & Co.